Repatha, a PCSK9 inhibitor, lowers cholesterol well, especially for those intolerant to statins, but its absolute risk ...

Good afternoon, everyone, and welcome to our first quarter of 2026 earnings call. Bob Bradway will lead the call today and be followed by a broader review of our performance by Murdo Gordon, Jay ...

Amgen has launched a late-stage program to test the feasibility of switching patients from weekly GLP-1 injections to its own ...

Discusses Positive Top Line Results From REVEAL-2 Phase III Trial in Chronic Thyroid Eye Disease May 5, 2026 8:00 ...

Lupron Depot (leuprolide acetate) is a brand-name injection prescribed for prostate cancer and other hormone-related conditions. Lupron Depot’s side effects may vary depending on the dosage and the ...

Q1 2026 Management View "We had a strong first quarter and are well positioned to achieve our objectives for the year," said (Chairman & CEO Robert Bradway), reiterating that 2026 is "a springboard ...

Sitting in the passenger seat of a car, a high school teen clutches an insulin needle beneath her pursed lips. She overlays ...

Repatha’s withdrawal from Denmark is best understood as an early signal of the impact of Most Favored Nation drug pricing ...

Osteoarthritis has no cure, but researchers have developed new therapies that help aging or damaged joints repair themselves ...

A federally funded team at the University of Colorado Boulder says its experimental injectable therapy could reverse joint ...